Citation Formats
The efficacy of tyrosine kinase inhibitor dasatinib on colonic mucosal damage in murine model of colitis
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

G. Can Et Al. , "The efficacy of tyrosine kinase inhibitor dasatinib on colonic mucosal damage in murine model of colitis," 11th Congress of ECCO - European Crohn’s and Colitis Organisation , Amsterdam, Netherlands, 2016

Can, G. Et Al. 2016. The efficacy of tyrosine kinase inhibitor dasatinib on colonic mucosal damage in murine model of colitis. 11th Congress of ECCO - European Crohn’s and Colitis Organisation , (Amsterdam, Netherlands).

Can, G., Ayvaz, S., Can, H., Karaboğa, I., Demirtaş, S., Akşit, H., ... Yılmaz, B.(2016). The efficacy of tyrosine kinase inhibitor dasatinib on colonic mucosal damage in murine model of colitis . 11th Congress of ECCO - European Crohn’s and Colitis Organisation, Amsterdam, Netherlands

Can, Güray Et Al. "The efficacy of tyrosine kinase inhibitor dasatinib on colonic mucosal damage in murine model of colitis," 11th Congress of ECCO - European Crohn’s and Colitis Organisation, Amsterdam, Netherlands, 2016

Can, Güray Et Al. "The efficacy of tyrosine kinase inhibitor dasatinib on colonic mucosal damage in murine model of colitis." 11th Congress of ECCO - European Crohn’s and Colitis Organisation , Amsterdam, Netherlands, 2016

Can, G. Et Al. (2016) . "The efficacy of tyrosine kinase inhibitor dasatinib on colonic mucosal damage in murine model of colitis." 11th Congress of ECCO - European Crohn’s and Colitis Organisation , Amsterdam, Netherlands.

@conferencepaper{conferencepaper, author={Güray Can Et Al. }, title={The efficacy of tyrosine kinase inhibitor dasatinib on colonic mucosal damage in murine model of colitis}, congress name={11th Congress of ECCO - European Crohn’s and Colitis Organisation}, city={Amsterdam}, country={Netherlands}, year={2016}}